Multicenter, multinational, prospective, randomized and double-blind study to compare the efficacy and safety of faropenem daloxato 300 mg orally twice daily for 10 days with amoxicillin-clavulanic acid 500/125 mg orally, three times a day for 10 days in the treatment of adult patients with community-acquired pneumonia

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2001
This article has no abstract
Epistemonikos ID: 88aa1f3ce5a12c54f24b29497229a0eb44821ade
First added on: Apr 16, 2025